Quality, safety, professional ethics are both essential objectives that our group aims to guarantee to their clients.

Both management tools to work with to ensure the required biofilm profiling of microbes, parasites and bions in agriculture and public health.
Basic research with bions, biomimetic properties and respecting the basic physiology of blood circulation which pulsates naturally in mammals and therefore in humans led to a novel and differentiated Heart Device.

W. Battistutti
Bioscientist
Lector

Protlab GPL Limited has been awarded:

Leaders in Bioanalytical Testing 2019


Best Early-Stage Biotechnology Company - UK
Most Innovative CVD Technology Platform 2019

Conferences / Congress

Presentation on the Human Genome Meeting 2017 from 5 to 7 February 2017, in Barcelona as well on the 19th International Conference on Obstetrics and Gynaecology from 16 to 17 February 2017, in London

UK Bioscience Forum 2017Furthermore on 'The Molecular Diagnostics Europe Conference', summit on 11 to 12 April 2017 in Lisbon, Portugal at the Sheraton Hotel.

Protlab participates in the UK Bioscience Forum 2017.

New Board Member

Mr John Erb (Chairman and CEO, CHF Solutions Inc., a NASDAQ listed company) has accepted to come on board of Protlab GPL, Ltd as a new director.
He has more than 35years experience in medical device industry.

Protlab GPL Pyramid

Credo ut intelligam - 'I believe so that I may understand'
Intellego ut credam - 'I think so that I may believe'
Anselm of Canterbury